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Introduction
The  endothelium  lining  all  blood  vessels  plays  an  essential 
role in the maintenance of tissue fluid homeostasis (Mehta and 
Malik, 2006). It finely controls the permeability of the vessel 
wall barrier to plasma proteins and small solutes via transcellular, 
caveolae-mediated transcytosis and paracellular, inter-endothelial 
junctional (IEJ) routes. Whereas IEJs are permeant to mol-
ecules with radii of 3 nm or less, caveolae-mediated vesicle 
trafficking  transports  different-sized  plasma  proteins  across 
the vascular barrier (Michel, 1996). The interrelationships be-
tween paracellular and transcellular pathways are not well 
understood. The loss of caveolin-1 (Cav-1) results in not only 
disappearance of caveolar structures but also destabilization of 
IEJs and formation of inter-endothelial gaps (Schubert et al., 
2002; Miyawaki-Shimizu et al., 2006). We surmised from these 
previous studies that opening of the paracellular route for 
albumin transport in Cav-1
/ mice might represent a gen-
eral mechanism by which Cav-1 influences IEJs and regulates 
junctional integrity.
In addition to the transport of plasma proteins and lipids, 
caveolae  compartmentalize  signaling  molecules  within  lipid 
raft microdomains (García-Cardeña et al., 1997). Cav-1 interacts 
with a variety of signaling molecules such as EGF receptor 
(EGFR),  c-Src,  phosphoinositide  3-kinase  (PI3K),  Gi,  and 
endothelial nitric oxide synthase (eNOS; also known as NOS 
type 3), and binding of proteins to Cav-1 often leads to their   
inactivation (Minshall et al., 2002; Mehta and Malik, 2006).   
Interestingly, eNOS inhibitors were shown to restore the in-
crease in paracellular permeability observed in Cav-1–deficient 
mice (Miyawaki-Shimizu et al., 2006), which suggests that eNOS 
activity is required for the opening of IEJs. In the present study, 
we addressed mechanisms by which eNOS-dependent redox 
E
ndothelial barrier function is regulated by adherens 
junctions (AJs) and caveolae-mediated transcellular 
pathways. The opening of AJs that is observed in 
caveolin-1
/ (Cav-1
/) endothelium suggests that Cav-1 
is necessary for AJ assembly or maintenance. Here, using 
endothelial cells isolated from Cav-1
/ mice, we show 
that Cav-1 deficiency induced the activation of endothelial 
nitric oxide synthase (eNOS) and the generation of nitric 
oxide (NO) and peroxynitrite. We assessed S-nitrosylation 
and nitration of AJ-associated proteins to identify down-
stream NO redox signaling targets. We found that the 
GTPase-activating protein (GAP) p190RhoGAP-A was 
selectively  nitrated  at  Tyr1105,  resulting  in  impaired 
GAP activity and RhoA activation. Inhibition of eNOS or   
RhoA  restored  AJ  integrity  and  diminished  endothelial   
hyperpermeability in Cav-1
/ mice. Thrombin, a media-
tor of increased endothelial permeability, also induced 
nitration  of  p120-catenin–associated  p190RhoGAP-A. 
Thus, eNOS-dependent nitration of p190RhoGAP-A rep-
resents a crucial mechanism for AJ disassembly and resul-
tant increased endothelial permeability.
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Cav-1
/ mice (Fig. S1). We observed an approximately two-
fold increase in eNOS phosphorylation at S
1177 (Fig. 1 a), the 
Akt-1 phosphorylation site known to regulate enzymatic activ-
ity of eNOS (Dimmeler et al., 1999). Phosphorylation of Akt-1   
at S
473 was also increased (Fig. 1 a), which indicates marked 
Akt-1 activation in Cav-1
/ endothelium. Basal nitric oxide 
(NO) generation determined by l-arginine replenishment was 
fourfold greater in Cav-1
/ MLVECs (Fig. 1 b). This finding 
signaling, which is normally held in abeyance by binding of 
eNOS to Cav-1 (Bucci et al., 2000), regulates IEJ integrity and 
thereby the permeability of the endothelial barrier.
Results and discussion
We first determined basal eNOS activity in murine lung vascular 
endothelial cells (MLVECs) isolated from wild-type (Wt) and 
Figure 1.  Cav-1 deficiency induces eNOS activation and AJ destabilization in endothelium. (a) Phosphorylation of eNOS at S
1177 and Akt-1 at S
473 in Wt 
and Cav-1
/ MLVECs; n = 3. Molecular mass standards are indicated next to the gel blots in kilodaltons. (b) Basal NO generation was measured in the 
absence or presence of l-NNA or NPA and 1400W in combination. Arrow, l-arginine replenishment. Scale bars are shown for 100 nM NO and 10 min. 
Bar plot, NO accumulation in a media over 20 min; mean ± SEM (error bars); *, P < 0.05 as compared with Wt control; n = 6. (c) Wt and Cav-1
/ 
endothelial monolayers stained for VE-cadherin, -catenin (green in overlays), F-actin (red), and nuclei (blue). Inter-endothelial gaps in Cav-1
/ monolayers 
are indicated by arrowheads. Bar, 10 µm. (d and e) Accumulation of -catenin at AJs was expressed as a mean pixel intensity of threshold area shown in d   
(threshold above intracellular background is in orange). (f) Area of inter-endothelial gaps was determined using the same set of images as in e; n = 17. 
Black circles and error bars in e and f indicate mean and SEM, respectively; *, P < 0.01 as compared with Wt control.843 p190RhoGAP-A nitration and endothelial permeability • Siddiqui et al.
p120-catenin (Wildenberg et al., 2006). We reasoned that the 
apparent organization of actin cytoskeleton into stress fibers 
in Cav-1
/ MLVECs (Fig. 1 c) might result from insufficient 
control of RhoA activity. p190A, a GTPase-activating protein 
(GAP), facilitates RhoA-GTP hydrolysis (Tatsis et al., 1998) 
and is a major regulator of RhoA activity at the level of AJs 
(Mammoto et al., 2007). SNO content, determined by the biotin-
switch assay (Jaffrey and Snyder, 2001), of AJ proteins was in-
distinguishable between Cav-1
/ and Wt endothelia, although in 
a control experiment we could detect SNO of -catenin in VEGF-
stimulated endothelial cells (Fig. 2 a). This finding raises the 
possibility that eNOS-redox signaling regulates integrity of AJs 
by other means.
When NO is accompanied by O2
 generation, it forms 
peroxynitrite.  The  diffusion-controlled  reaction  of  NO  with 
O2
 is a likely source of peroxynitrite in cells and in vivo 
(Beckman et al., 1990; Jourd’heuil et al., 2001). The resulting 
peroxynitrite rapidly decomposes in the presence of ubiquitous 
CO2 to produce nitrate (NO3
) as a stable end product as well 
as carbonate (CO3
) and nitrogen dioxide (
NO2) radicals 
(Bonini et al., 1999; Augusto et al., 2002), whose concerted 
action redirects peroxynitrite reactivity toward nitration of 
protein tyrosine residues (Santos et al., 2000). A direct mea-
surement of peroxynitrite in cells is precluded by the extremely 
short lifetime of peroxynitrite at physiological pH and by the 
presence of metals, reductants, and CO2. Because peroxyni-
trite formation depends on both O2
 and NO and produces 
NO3
  as  the  only  stable  product  after  oxidant  decomposi-
tion, the use of superoxide scavengers followed by measure-
ment of nitrite (NO2
) accumulation provides an assessment 
of peroxynitrite formation (Bonini et al., 2002). Agents such   
as  polyethylene  glycol-superoxide  dismutase  (PEG-SOD) 
and 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy (TEMPOL) in 
adequate concentrations outcompete NO for O2
, thus favor-
ing NO autoxidation and NO2
 accumulation (Hoffman et al., 
2003).  Here  we  used TEMPOL/SOD-dependent  NO2
  ac-
cumulation to assess peroxynitrite formation. Both scavengers 
had marginal effects on accumulation of nitrite resulting from 
basal NO production in Wt cells (Fig. 2 b); in contrast, ac-
cumulation of nitrite was significantly higher in Cav-1
/ cells 
(Fig. 2 b). Consistent with this observation, Cav-1 deficiency   
was accompanied by a twofold increase in O2
 generation 
(Fig. 2 c), as measured by formation of 2-hydroxyethidium 
(EOH), a product of dihydroethidium (DHE) oxidation. Fur-
thermore, adding tetrahydrobiopterin (BH4) to these cells, but 
not l-arginine, restored O2
 generation to the level seen in Wt 
cells (Fig. 2 c), which suggests that BH4 deprivation-mediated 
uncoupling eNOS from NO generation is the primary mecha-
nism of O2
 generation in the Cav-1
/ endothelial cells. We 
thus concluded that up-regulation of eNOS activity in Cav-1
/ 
endothelium results in an augmented generation of both NO 
and O2
 and thereby the formation of peroxynitrite.
We next determined the nitration of AJ proteins by probing   
immunoprecipitated proteins with anti-nitrotyrosine antibody 
(3-N). We failed to detect any change in nitration of either - or 
p120-catenins in Cav-1
/ endothelial monolayers (Fig. 2 d); 
however, nitration of p190A was significantly increased (Fig. 2 e). 
is consistent with the reported increased plasma NO concentra-
tion in Cav-1–deficient mice (Miyawaki-Shimizu et al., 2006). 
Nitro-l-arginine (l-NNA) treatment at an inhibitory concentra-
tion for nNOS, and eNOS prevented NO generation, whereas 
treatment with 1400W and N-propyl-l-arginine (NPA) in com-
bination (at inhibitory concentrations for iNOS and nNOS) had 
a marginal effect (Fig. 1 b). We concluded that Cav-1 deficiency 
in the endothelium resulted in Akt-1 and eNOS activation and 
an augmented NO production, which is in agreement with the 
role  of  Cav-1  in  inhibiting  eNOS  activity  in  endothelium 
(García-Cardeña et al., 1997).
Next we determined the effects of Cav-1 deficiency on 
adherens junction (AJ) integrity, the primary adhesive complex 
in the continuous endothelium responsible for regulating junctional 
permeability. We did not observe any significant change in the 
expression of AJ proteins in Cav-1
/ MLVECs compared with 
Wt cells (Fig. S1 b), which is in contrast to the difference reported 
for the brain endothelial cells (Song et al., 2007). This incon-
sistency might reflect tissue specificity (i.e., continuous vs. the 
highly restrictive brain endothelial barrier). Whereas AJs play a 
primary role in the mechanism of AJ integrity in the continuous 
endothelium, they are secondary in maintaining brain–blood bar-
rier function (Nitta et al., 2003). Integrity of AJs was assessed 
by immunofluorescent staining for VE-cadherin, the homotypic 
adhesive protein of AJs (Corada et al., 1999), and -catenin. 
Both proteins accumulated at the cell border; however, cluster-
ing of VE-cadherin at the cell surface of Cav-1
/ endothelium 
was markedly reduced (Fig. 1 c). VE-cadherin formed discrete 
patches on the Cav-1
/ endothelial cell surface; in contrast,   
VE-cadherin was organized as bands encircling the Wt endothe-
lial cells. Accumulation of -catenin at AJs, also used to assess 
AJ integrity, was significantly reduced in Cav-1
/ endothelium 
(Fig. 1, c–e). Cav-1
/ monolayers were characterized by the 
presence of many inter-endothelial gaps (Fig. 1, c and f). l-NNA 
treatment partially restored the accumulation of -catenin 
at AJs and resealed the gaps in Cav-1
/ monolayers (Fig. 1, 
c and e). Although AJs remained somewhat fragmented, they 
appeared to assemble as bands connecting adjacent cells. Inter-
estingly, the PI3K p110 isoform, which acts upstream of the 
Akt-1–eNOS signaling node, was shown to negatively regulate 
the integrity of AJs during inflammation by inducing the asso-
ciation of VE-cadherin with Pyk2 (Cain et al., 2010). It is likely 
therefore that Cav-1 deficiency is also accompanied by PI3K 
activation, and the destabilization of VE-cadherin adhesion seen 
in the Cav-1
/ monolayers might result from independent paral-
lel signaling events. Nevertheless, our data suggest that Cav-1 
modulates permeability of endothelial barrier, in part, through 
its negative regulation of eNOS activity.
To address mechanisms of eNOS modulation of AJ integ-
rity, we determined the effects of NO on modification of AJ pro-
teins. NO can lead to S-nitrosylation of cysteine, the covalent 
attachment of a NO group to the thiol side chain (Lima et al., 
2010), and thus influence protein function. S-nitrosylation of 
-catenin was shown to facilitate destabilization of AJs in response 
to VEGF signaling (Thibeault et al., 2010). Therefore, we deter-
mined S-nitrosothiol (SNO) content of - and p120-catenins and 
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of p190A, which could thereby inhibit its GAP activity. We 
found a marked decrease in p190A phosphorylation in Cav-1
/ 
MLVECs (Fig. 3 a). We next addressed whether Y
1105, the phos-
phorylation site critical for p190A activity (Roof et al., 1998), 
might be targeted for nitration. Mutation of Y
1105, but not Y
1087, to 
phenylalanine (Y→F) prevented the chemically induced nitra-
tion of p190A by 3-morpholinosydnonimine (SIN-1; Fig. 3 b). 
SIN-1 also induced nitration of endogenous and transiently ex-
pressed Wt p190A but not of p190RhoGAP-B (Fig. 3 b).
Down-regulation of p190A activity results in RhoA ac-
tivation (Vincent and Settleman, 1999), which may increase 
junctional permeability (Holinstat et al., 2006). We thus deter-
mined whether nitration of p190A results in RhoA activation in 
the Cav-1
/ endothelium. For this, we assessed RhoA activity 
using the FRET-based RhoA biosensor (Pertz et al., 2006). Ratio 
images revealed a twofold increase in RhoA activity in Cav-1
/ 
monolayers compared with Wt (Fig. 3, c and d). We detected 
uniform RhoA activity from the edge of the cell inwards with 
We also found marked reduction in p190A nitration in Cav-1
/ 
endothelial cells pretreated with TEMPOL and in MLVECs 
isolated from lung vessels of Cav-1/eNOS double knockout 
mice (Fig. 2 e). Nitration of p190A also appeared to be revers-
ible because scavenging of O2
 significantly reduced the ni-
trated protein levels, although the p190A expression level itself 
remained  unchanged  (Fig.  2  e). We  speculate  that  nitration, 
which in some cases targets proteins for proteolytic degradation 
(Grune et al., 1998), does not regulate the metabolism and turn-
over of p190A. The dogma of irreversible nitration of proteins 
is under debate, and it is also now increasingly evident that the 
action of peroxynitrite might be specific (Aulak et al., 2004; 
Görg et al., 2007).
Nitration compromises protein function by altering tyro-
sine phosphorylation (Gow et al., 1996). The ability of p190A 
to hydrolyze RhoA is regulated by c-Src and FAK phosphoryla-
tion of p190A (Chang et al., 1995; Holinstat et al., 2006). There-
fore, we tested whether nitration alters tyrosine phosphorylation 
Figure  2.  Peroxynitrite  generation  in   
Cav-1
/ endothelium and nitration of p190A. 
(a)  S-nitrosylation  of  -  and  p120-catenins, 
and  p190A.  Proteins  were  co-immunopre-
cipitated  with  specific  Abs,  and  precipitates 
were probed with HRP-avidin; results of two 
independent experiments are shown; n = 4. 
Note that the -catenin band is indicated by 
an arrow. SNO of -catenin in VEGF-treated 
cells  is  a  positive  control.  Molecular  mass 
standards are indicated next to the gel blots 
in kilodaltons. (b) The bar plot shows nitrite ac-
cumulation in the presence of SOD and TEM-
POL; mean ± SEM (error bars); *, P < 0.05 as 
compared with Wt control; n = 4. (c) Bar plot 
shows  the  fluorescence  emission  of  EOH  at 
580 nm; mean ± SEM (error bars); *, P < 0.05   
as  compared  with  Wt  control;  n  =  4.   
(d) - and p120-catenins and (e) p190A were 
co-immunoprecipitated with specific Abs, and 
precipitates were probed for nitrotyrosine (3-N).   
Results  of  two  independent  experiments  are 
shown; n = 4. (e) Cav-1 deletion induced the 
nitration  of  p190A,  which  was  reduced  by 
TEMPOL treatment and in cells isolated from 
lungs of Cav-1/eNOS double knockout mice 
(DKO).  (e,  right)  Bar  plot;  fold  increase  in 
p190A nitration normalized to p190A load-
ing; mean ± SEM (error bars); *, P < 0.05 as 
compared with Wt; n = 4.845 p190RhoGAP-A nitration and endothelial permeability • Siddiqui et al.
To demonstrate the causal link between RhoA activity and 
destabilization of AJs, we attempted to restore integrity of AJs in 
Cav-1
/ MLVECs by inhibiting RhoA. Treatment of Cav-1
/ 
endothelium with the Rho inhibitor C3-transferase signifi-
cantly reduced phosphorylation of myosin light chain (MLC), a 
very little and infrequent accumulation at cell edges and along ex-
tensions (Fig. 3 c), which is consistent with the distribution of 
active RhoA in other nonmigrating cells (Pertz et al., 2006). Nota-
bly, we observed a fourfold increase in RhoA activity by the pull-
down of RhoA-GTP with Rhotekin beads (Fig. 3 e).
Figure 3.  Nitration of p190A induces RhoA activation in endothelial cells. (a) p190A was co-immunoprecipitated and precipitates were probed for phospho-
tyrosine (PY20) and p190A; n = 3. Molecular mass standards are indicated next to the gel blots in kilodaltons. (b) Human microvascular endothelial cells 
(dermal) overexpressing HA-tagged p190A, p190B, or p190A mutants Y1105F and Y1087F were treated with SIN-1. Nitration of endogenous p190A 
and exogenously expressed proteins was determined with 3-N antibody. Exogenous proteins were co-immunoprecipitated with anti-HA antibody; n = 3. 
(c) Live imaging of a genetically encoded FRET-based RhoA biosensor. Representative YFP and FRET/CFP ratio confocal images. Pixel intensities of ratio 
images were scaled from 0 to 5 and color-coded as indicated on the left. Bar, 10 µm. (d) FRET/CFP emission ratio; mean and SEM are as in Fig. 1 e; 
n = 13; *, P < 0.01. (e) RhoA-GTP was pulled down with Rhotekin-RBD beads. Resultant precipitates and 5% of cell extracts were probed for RhoA; results 
of two independent experiments are shown; n = 4. Molecular mass standards are indicated next to the gel blots in kilodaltons.JCB • VOLUME 193 • NUMBER 5 • 2011   846
To  address  the  role  of  Cav-1–eNOS  interaction  in  the 
mechanism  of  increased  paracellular  permeability  in  vivo,  we 
recorded fluid shift in isolated-perfused murine lungs by the 
gravimetric method in response to a standard perturbation of the 
trans-endothelial oncotic pressure gradient (c–i; Fig. 4 d). 
Elevating perfusate albumin from 0 to 10 g/100 ml caused sig-
nificantly greater dehydration of lungs of Cav-1
/ mice than in 
Wt control (Fig. 4 d), which indicates much faster equilibration 
of fluid across the endothelium devoid of Cav-1 expression. The 
lung weight gain (during the 40–50th min of the experiment) 
was fit to a double exponential function characterizing the fast and 
slow filtration processes (Table S1). The filtration rate calculated 
  downstream effector of RhoA/ROCK, in Cav-1
/ cells (Fig. S2). 
It also rescued -catenin accumulation at AJs and restored 
permeability of Cav-1
/ monolayers to the Evans blue albumin 
(EBA) tracer (Fig. 4, a–c). Treatment of Cav-1
/ endothelium 
with Cav-1 scaffold domain (CSD)–antennapedia (AP) fusion pep-
tide, which binds to and suppresses eNOS catalytic activity (Bucci 
et al., 2000), superoxide scavenger TEMPOL, and l-NNA as 
well as Cav-1/eNOS deficiency (DKO) also restored the integrity 
of AJs and the permeability of Cav-1
/ monolayers (Fig. 4, a–c). 
We concluded therefore that nitration of p190A provides a re-
versible switch mechanism regulating RhoA activity and thereby 
endothelial barrier integrity.
Figure 4.  Restoration of normal paracellular permeability   
in Cav-1
/ endothelial monolayers and vessels by in-
hibition of either RhoA or eNOS. (a) Immunofluorescent 
staining of MLVECs isolated from Cav-1
/ and Cav-1/
eNOS double knockout (DKO) mice for -catenin (green), 
F-actin (red), and nuclei (blue). Cav-1
/ cells were treated 
with Rho inhibitor C3 transferase and AP-CSD peptide.   
Bar, 10 µm. (b) -catenin accumulation at AJs as in Fig. 1 e;   
*, P < 0.01 as compared with Wt control; **, P < 0.01 
as  compared  with  Cav-1
/;  n  =  10.  (c)  Endothelial 
permeability to EBA; mean and SEM are as in Fig. 1 e;   
*, P < 0.01 as compared with Wt control; **, P < 0.05 as 
compared with Cav-1
/; n = 4. (d) Lung weight changes 
after  a  step  increase  in  transvascular  oncotic  pressure 
gradient. Recordings were smoothed by averaging suc-
cessive groups of five points. Lungs isolated from Wt and 
Cav-1
/ mice were perfused with 0% BSA for 10 min, 
with 10% BSA for 30 min, and with 0% BSA for 10 min; 
an additional Cav-1
/ group received AP-CSD peptide 
starting at 10 min of BSA profusion. AP-CSD peptide re-
versed lung weight loss during high albumin perfusion in 
Cav-1
/ lungs and largely restored the transvascular 
fluid filtration rate between 40 and 50 min. (e) The fil-
tration rate was calculated from the initial slope of slow 
exponential component of lung weight gain; mean and 
SEM are as in Fig. 1 e; *, P < 0.05 as compared with 
Wt control; n = 5–9.847 p190RhoGAP-A nitration and endothelial permeability • Siddiqui et al.
The NO redox endothelial permeability-increasing mech-
anism described in this paper may contribute to deregulation of 
tissue fluid homeostasis during inflammation, which is known 
to be accompanied by loss of p190A activity and activation 
of RhoA (Mammoto et al., 2007). Therefore, we determined 
whether stimulation of endothelial cell monolayers with a pro-
inflammatory mediator such as the serine protease thrombin 
induces p190A nitration. Thrombin proteolytically cleaves and 
from the initial slope of the slow exponential component was 
significantly greater in Cav-1
/ (5.5 ± 0.6 µl/min; n = 5) than 
in Wt (4.1 ± 0.3 µl/min; n = 9) lungs (Fig. 4 e). Perfusion with 
AP-CSD peptide that reanneals open IEJs (Fig. 4 a) restored 
transvascular fluid filtration in Cav-1
/ lungs to the Wt values 
(Fig. 4, d and e). We infer therefore that Cav-1 regulates the 
permeability of the paracellular or AJ pathways mainly by func-
tioning to restrain the eNOS activity.
Figure 5.  eNOS-dependent NO-redox signaling disrupts AJ integrity. (a) Immunofluorescent staining of HPAECs for eNOS (green) and -cat (red). 
DAPI (blue) is shown before and after stimulation with 50 nM -thrombin. a1 and a2 are enlarged views of boxed regions; inter-endothelial gaps are 
indicated by arrowheads. Bars, 10 µm. (b) eNOS accumulation at AJs was measured as in Fig. 1 e with some modification (see Materials and methods);   
*, P < 0.05 as compared with Wt control; n = 6. -Thrombin induced transient accumulation of eNOS at AJs. (c and d) -Thrombin induced transient 
interaction between eNOS and p190A and nitration of p190A. eNOS and p190A were co-immunoprecipitated with specific Abs from HPAECs stimulated 
with 50 nM -thrombin. Precipitates were probed for p190A, eNOS, 3-N, and p120-catenin. Molecular mass standards are indicated next to the gel 
blots in kilodaltons. (e) Model showing that Cav-1–mediated recruitment of eNOS into caveolar domain allows formation of stable endothelial VE-cadherin 
adhesions, which restricts the permeability of the paracellular route to plasma proteins. Deficiency in Cav-1 or release of eNOS from caveolae results in 
activation of eNOS, translocation of eNOS to AJs, and transient interaction with p190A. Peroxynitrite, a product of NO and O2
●, inhibits p190A activ-
ity by nitrating Y
1105. Activation of RhoA leads to reorganization of the actin cytoskeleton, actomyosin contractility, destabilization of AJs, and increased 
vascular permeability via the paracellular pathway.JCB • VOLUME 193 • NUMBER 5 • 2011   848
Cell culture, treatments, and transfection
Cav-1
/ and matching control mice of C57bl/6 background were ob-
tained from The Jackson Laboratory (JAX mice and services). Cav-1/eNOS 
double knockout was produced as described previously (Zhao et al., 2009). 
MLVECs were isolated as described previously (Garrean et al., 2006), 
with some modification. In brief, 3–4-wk-old mice were anesthetized by 
using isoflurane (2.5% in room air) according to the protocol approved 
by the University of Illinois Animal Care Committee. Depth of anesthesia 
was ascertained by loss of pain reflex to a vigorous paw pinch. After 
exsanguination, the lung was perfused with sterile HBSS supplemented 
with antibiotics. Lung was removed, minced, and digested with collagenase 
A (1.0 mg/ml in HBSS) for 60 min at 37°C on shaker. The released cells 
were centrifuged at 200 g for 10 min. The pellet was suspended in 10 ml 
of suspension buffer (Ca
2+- and Mg
2+-free PBS containing 0.5 g/100 ml 
bovine serum albumin, 2 mM EDTA, and 4.5 mg/ml d-glucose), and fil-
tered through a 200-µm mesh sterile filter. The cell suspension was incubated 
with 10 µg of anti–mouse PECAM-1 antibody on ice for 1 h, centrifuged   
to remove unbound antibody, and washed once with suspension buffer. 
The  cells  were  incubated  with  Dynabeads  M-450  (Sheep  anti-rat  IgG) 
for 60 min at 4°C. The cells attached to Dynabeads were trapped in a 
magnetic column to separate a subpopulation of PECAM-1–positive cells, 
washed, and resuspended in endothelial growth medium EGM-2 MV 
medium (Lonza), supplemented with 10% FBS (Invitrogen), and seeded in 
Matrigel-coated culture dishes (BD).
MLVECs and human lung microvascular endothelial cells (HMVEC-Ls; 
Lonza) were grown in EGM-2 MV medium (Lonza) supplemented with 
15% FBS (Invitrogen). HPAECs (Lonza) were grown in EGM-2 medium 
(Lonza) supplemented with 15% FBS (Invitrogen). Endothelial cells were 
used at passages 2–6. Human microvascular endothelial cell (HMECs; 
dermal; Lonza) were grown in MCDB 131 medium (Invitrogen) supple-
mented with 10% FBS, 0.003 µg/ml h-EGF, 0.001 mg/ml hydrocortisone, 
and l-glutamine.
For measurement of basal NO generation, cells were incubated 
in  l-arginine–free EBM media (Lonza) for 2 h. Cells were treated with   
4 µM NPA, 4 µM 1400W, 4 µM l-NNA, and 100 µM SIN-1 for 30 min; 
and with 150 U/ml PEG-SOD, 100 µM TEMPOL, 2 µg/ml Rho inhibitor 
C3 transferase, and 6 µM AP-CSD peptide for 2 h. 70–80% conflu-
ent monolayers were transfected using FuGENE HD (Rhoche) and Lipo-
fectamine 2000 (Invitrogen) transfection reagents in accordance with the 
manufacturer’s instructions.
Co-immunoprecipitation and Western blotting
Cells were lysed in modified RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM   
NaCl, 1 mM EDTA, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% 
SDS, 1 mM Na3VO4, 10 µg/ml leupeptin, 10 µg/ml aprotinin, and 0.1 mM 
PMSF). For co-immunoprecipitation experiments, 350 µg of total protein 
was incubated with 15 µg of antibody at 4°C, and precipitates were 
collected with protein A/G agarose beads. Densitometry of blots was per-
formed using ImageJ software (National Institutes of Health).
RhoA-GTP pull-down assay
RhoA activity was determined by pull-down assays using GST-Rhotekin 
beads (Knezevic et al., 2007). Cells were lysed in 50 mM Tris-HCl, pH 
7.5, 10 mM MgCl2, 0.5 M NaCl, 1% Triton X-100, 0.5% sodium deoxy-
cholate, 0.1% SDS, 10 µg/ml leupeptin, 10 µg/ml aprotinin, and 0.1 mM 
PMSF. Cell lysates were incubated with GST-RBD beads at 4°C and bound 
proteins were analyzed by Western blotting. 5% of cell lysates were used 
to detect total RhoA.
NO measurement
NO formation was measured using porphyrinic NO electrodes (Brovkovych 
et al., 1999). Electrodes were calibrated using a stock solution of NO-
saturated water. The NO electrode was placed onto the cell surface and 
two additional electrodes were added into the solution to generate a 650-mV 
potential. The system was coupled to a FAS1 femtostat and a personal 
computer with electrochemical software (Gamry Instruments). The electrode 
current, which is proportional to NO concentration, was measured as a 
function of time.
Nitrite measurement
Nitrite accumulation in cell culture media was assessed by a chemilumines-
cence assay (Bonini et al., 2002) using an NO Analyzer (NOA 280i;   
GE Healthcare). Authentic NaNO2 solutions of known concentrations   
were used as standards. All measurements were performed relative to cell-
free controls.
activates the protease-activated receptor PAR-1 on the endothe-
lial surface, leading to increased intracellular calcium concen-
tration and activation of eNOS (Motley et al., 2007). Challenge 
of human pulmonary artery endothelial cells (HPAECs) with   
-thrombin resulted in translocation of eNOS to AJs and a transient 
interaction between eNOS and p190A and nitration of p190A 
(Fig. 5, a–d). Nitrated p190A also remained bound to p120-
catenin (Fig. 5 d). Thus, we suggest that the signaling mechanism 
responsible for increased vascular permeability described in this 
study may be important in inflammatory diseases, and hence we 
propose it represents a novel anti-inflammatory therapeutic target.
In conclusion, our study demonstrates that paracellular 
permeability of the endothelium is finely regulated by constitu-
tive Cav-1–dependent inhibition of eNOS activity (Fig. 5 e). De-
ficiency in Cav-1 or activation of eNOS in conjunction with O2
 
production results in nitration of p190A and the concomitant ac-
tivation of RhoA, which induces AJ destabilization and increased 
endothelial permeability. Because of the causal relationship of 
eNOS-specific signaling to the impairment of p190A activity, 
this mechanism induces RhoA activation in endothelial cells. 
In fibroblasts, however, Cav-1 depletion induces Src-dependent 
activation of p190A, resulting in loss of cell polarity and im-
paired wound healing (Grande-García et al., 2007). In contrast, 
in endothelial cells, Cav-1 knockdown increases directional 
migration (Gonzalez et al., 2004); thus, our findings help to 
inform the unique role of Cav-1 expression on p190A activity 
in endothelial cells and how Cav-1 regulates the permeability of 
the endothelial junctional barrier.
Materials and methods
Antibodies and reagents
We used anti-HA (clone 16B12; Covance), anti-phosphotyrosine (PY20), 
and PECAM-1 (BD); anti–VE-cadherin, anti–-actin, anti-, and anti-p120 
catenins; anti-RhoA, anti-eNOS, and anti–Cav-1 (Santa Cruz Biotech-
nology,  Inc.);  anti-p190RhoGAP  (Sigma-Aldrich);  anti-nitrotyrosine,  anti-
Akt,  and  anti–MLC  2;  and  phospho-eNOS-Ser
1177,  phospho-Akt-Ser
473, 
and  phospho-MLC2-Thr
18/Ser
19  (Cell  Signaling  Technology).  Second-
ary  Abs  were  HRP-conjugated  donkey  anti–mouse,  anti–rabbit,  and 
anti–goat (Jackson ImmunoResearch Laboratories, Inc.); TRITC-, FITC-, and 
Cy-5-conjugated donkey anti–mouse, anti–goat, and anti–rabbit (Jackson 
ImmunoResearch Laboratories, Inc.), Alexa Fluor 532 phalloidin, and 
DAPI (Sigma-Aldrich).
We used protein A/G beads (Santa Cruz Biotechnology, Inc.), DHE, 
and Dynabeads M-450 (Invitrogen). We also used a Rho activation assay 
kit and Rho inhibitor C3 transferase (Cytoskeleton), SIN-1 (EMD), NPA,   
l-NNA, and 1400W (Cayman Chemical), PEG-SOD, TEMPOL, (6R)-5,6,7,8-
tetrahydrobiopterin dihydrochloride (BH4), l-arginine, sodium iodide, and 
sodium nitrite (Sigma-Aldrich), as well as AP-CSD peptide (EMD).
Expression constructs, primers, and RT-PCR
HA-tagged  rat  p190A  and  p190B,  Y1105F,  and  Y1087F  mutants  of 
p190A were gifts from S.J. Parsons (University of Virginia, Charlottesville, 
VA); the RhoA biosensor was from K. Hahn (University of North Carolina 
at Chapel Hill, Chapel Hill, NC). The mRNA was assessed by quantitative 
real-time PCR (Rajasingh et al., 2008). Primer and probe sequences were 
as  follows:  Cav-1  forward,  5-CAGCATGTCTGGGGGTAAAT-3,  and   
reverse, 5-TGCTTCTCATTCACCTCGTCT-3; Cav-2 forward, 5-TGTTTCT-
AGCCATCCCCTTG-3, and reverse, 5-ACCATGAGGCAGGTCTTCAC-3; 
eNOS forward, 5-TCTGCGGCGATGTCACTATG-3, and reverse 5-CATG-
CCGCCCTCTGTTG-3;  VE-cadherin  forward,  5-GTGGATGAGCCCCC-
TGTCT-3; and reverse, 5-CAGCGGTTTCTTCTGGTTTTCT-3; and Vw-F for-
ward, 5-GCTTCCAACTGAACTGTGAGACCT-3; and reverse, 5-GGCTGT-
GATGTCTTTGCAATCAG-3. The relative mRNA expression was normalized 
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Measurement of intracellular superoxide
Cells plated in a 96-well plate were left untreated or incubated with 50 µM 
BH4 or 500 µM l-arginine for 30 min, then treated with 50 µM DHE 
for 1 h. Emission of EOH, a product of DHE oxidation, at  = 580 nm, 
was measured using a SpectraMax M5e Multi-Mode Microplate Reader 
  (Molecular Devices).
SNO measurement
SNO content of junctional proteins was detected by biotin-switch method 
using the S-nitrosylated Detection Assay kit (Cayman Chemical) accord-
ing to the manufacturer’s instructions. The biotin-labeled proteins were precipi-
tated  with  ice-cold  acetone,  and  350  µg  of  total  protein  was  used  for 
co-immunoprecipitation with specific Abs. SNO content was detected with 
SNO detection reagent I on Western blots. The same blot was reprobed for 
protein of interest.
Immunofluorescence staining and image analysis
Cell were fixed with 4% paraformaldehyde, permeabilized with 0.2% Tri-
ton X-100, and stained as described previously (Komarova et al., 2002). 
Samples were mounted with ProLong-Gold antifade reagent (Invitrogen). 
Z-stack images were obtained using a confocal microscope (LSM 510 Meta; 
Carl Zeiss) equipped with a 63×, 1.2 NA water immersion objective lens 
and Ar ion and dual HeNe lasers, and driven by LSM software. 12-bit 
images were analyzed using MetaMorph software (Molecular Devices) 
and  prepared  for  illustration  in  Photoshop  (Adobe).  Projection  images 
were generated by collecting the maximum pixel intensity from each image 
of the z stack and by projecting pixel intensity onto the single (projection) 
image. The relative accumulation of -catenin (mean fluorescence intensity) 
at AJs and the area of gaps were measured on projected images. The 
12-bit images were thresholded by subtracting intracellular background,   
and the mean fluorescence intensity at AJs was measured. For measure-
ment of eNOS accumulation at AJs, the corresponding VE-cadherin image 
was used to generate a binary mask within 0 (outside of AJs) and 1 (AJs 
area) values after subtracting intracellular background, and the eNOS 
image was multiplied by a binary mask image for VE-cadherin. The mean 
fluorescence intensity of eNOS at AJs was then measured as described for 
-catenin. Gap area was expressed as a percentage of the area outside 
of the cell.
Live cell imaging and image processing
Cells were imaged in phenol-free EBM media (Lonza) supplemented with 
5% FBS at 37°C maintained by the stage heater (Tempcontrol-37; Carl 
Zeiss). Z-stack images were obtained using a confocal microscope (LSM 
510 Meta; Carl Zeiss) equipped with a 63×, 1.2 NA water immersion ob-
jective lens and Ar ion and dual HeNe lasers. For emission ratio imaging, 
we acquired 12-bit CFP ( = 458 nm; BP500/20), FRET ( = 458 nm; 
LP530), and YFP ( = 514 nm; LP530) images. All images were processed 
and analyzed using MetaMorph software. The FRET image was used to 
generate a binary mask within 0–1 values. To generate a ratio image re-
flecting RhoA activity, the FRET image was first multiplied by a binary mask 
image and then divided by the CFP image. The ratio images were rescaled 
to the lower value and a linear pseudocolor table was applied to generate 
the color-coded image map. The z stack FRET/CFP emission ratio images 
were used to generate the projection image. The relative RhoA activity was 
expressed as mean pixel intensity.
Endothelial barrier permeability measurement
The permeability of MLVECs monolayer to EBA was determined as de-
scribed previously (Patterson et al., 1992). Cells were grown to confluence 
on transwell inserts with a 0.4 µm pore size. Upper (luminal) and lower 
(abluminal) chambers were filled with HBSS containing 0.5% BSA and 
20 mM Hepes. After a 30-min equilibration period, the luminal chamber 
was loaded with 0.057% EBA. Samples from the abluminal chamber were 
collected every 5 min for 1 h. EBA concentration was calculated from the 
optical density measured at 620 nm with the aid of the SpectraMax Plus 
microplate spectrophotometer (Molecular Devices). The rate of EBA clear-
ance from luminal chamber was determined by linear regression between 
5 and 60 min.
Perfusion of mouse lungs and measurement of transvascular  
fluid filtration
Murine lung preparations from WT and Cav-1
/ male mice (C57bl/6 
strain) were performed according to an approved protocol of the Univer-
sity of Illinois at Chicago Animal Care Committee (Vogel et al., 2006). In 
brief, isolated lung preparations were perfused with RPMI medium at con-
stant flow (2 ml/min), temperature (37°C), and venous pressure (4 cm H2O). 
The preparation was ventilated at a rate of 120 breaths per min, at constant 
peak inspiratory (10 cm H2O) and end expiratory pressures (2 cm H2O). 
The lung weight change was recorded by a force-displacement transducer 
(Model FT03C; Grass Technologies). All lung preparations underwent a 
10-min equilibration perfusion to establish isogravimetric conditions followed 
by a 30-min step change in perfusate albumin concentration (g/100 ml) 
of albumin from 0 to 10. In some cases, AP-CSD (final concentration of   
10 µM) was added into the high-albumin perfusate between minute 20 
and 40 from the beginning of perfusion. The fluid filtration rate was ob-
tained by fitting a double exponential growth curve, y0 = a(1  e
Ka t) + 
b(1  e
Kb t), to the lung weight gain upon removal of albumin. The fast 
exponential component, which was of relatively low amplitude and co-
incident with the change of solution, most likely represented the effect of the 
shift in solution viscosity. The slow exponential component represented fluid 
filtration across the vessel wall induced by the change in oncotic pressure. 
The filtration rate was determined from the initial slope of this component 
extrapolated to zero time.
Statistical analysis
Data handling was performed using Sigma Plot software (SPSS). For statis-
tical analysis, a paired two-tailed Student’s t test was used to compare data 
between two groups.
Online supplemental material
Fig. S1 provides a characterization of primary MLVECs. Fig. S2 shows the 
effect of a Rho inhibitor on phosphorylation of MLC 2 in Cav-1
/ endothe-
lium. Table S1 summarizes the parameters of transvascular fluid filtration 
across the microvessel wall in isolated lungs. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.201012129/DC1.
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